Home / Journals Science Journal of Chemistry / Synthesis, Design, and Biological Evaluation of Heterocyclic Compounds
Synthesis, Design, and Biological Evaluation of Heterocyclic Compounds
Submission DeadlineJun. 25, 2020

Submission Guidelines: http://www.sciencepublishinggroup.com/home/submission

Lead Guest Editor
Abdulrahman Alharbi
Chemistry Department, Faculty of Science, King Abdul-Aziz University, Jeddah, Westren Area, Saudi Arabia
Guest Editors
  • Khalid AL-Shaikh
    Chemistry Department, Faculty of Science,King Abdul-Aziz University, Jeddah, Saudi Arabia
  • Ahmed El-Mahdy
    Chemistry Department, Faculty of Science, Assiut University, Assiut, Egypt
  • Dr Shatha Alaqeel
    Department of Chemistry ,King Saud University, Riyadh, Saudi Arabia
  • Khalid Ali Khan
    Chemistry Department, Faculty of Science, King Abdul-Aziz University, Jeddah, Saudi Arabia
  • Ram Singh
    Department of Applied Chemistry,Delhi Technological University, Delhi, India
  • Rasha Hassan
    Faculty of Pharmacy,Cairo University, Cairo, Egypt
  • Erin Carlson
    Department of Chemistry, University of Minnesota, Minneapolis, USA
  • Gavin Tsui
    Department of Chemistry, The Chinese University of Hong Kong, Hong Kong, China
  • Mohamed Zidan
    Department of Chemistry, King Fahad University, Dharan, Saudi Arabia
  • Imad Abu-Yousef
    Department of Biology, Chemistry and Environmental Sciences, American University of Sharjah, Sharjah, United Arab Emirates
  • FUJINO Tomoko
    Department of Chemistry, The University of Tokyo, Tokyo, Japan
  • Abeer Al-Romaizan
    Department of Chemistry, King Abdul Aziz University, Jeddah, Saudi Arabia
  • Faisal Aqlan
    Department of Chemistry, University of Jeddah, Jeddah, Saudi Arabia
  • Mohamed Azaam
    Department of Chemistry, University of Tanta, Tanta, Egypt
  • Guangcheng Wang
    Department of Chemistry and Chemical Engineering, Jishou University, Jishou, Hunan, China
  • David Scott
    Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, USA
  • Saravanabava J
    Department of Chemistry, Madras University, Chennai, Tamil nadu, India
  • Narendra Nirawan
    Department of Chemistry, S. D. Govt. College, Beawar, India
  • Ozgul Birel
    Department of Chemitry, Mugla Sitki Kocman University, Mugla, Turkey
  • Ahmed El-Ghorab
    Faculty of Science, Chemistry Department, ALJOUF University, Jouf, Saudi Arabia
  • Jihed Brahmi
    Departement of Chemistry Monastir Tunisia, Monastir, Sk, Tunisia
Introduction
Due to the spread of many diseases, as well as the resistance of many bacteria, fungi, and viruses for medicines, it has become necessary to prepare, synthesize, and improve many medicines.
One of the most important compounds that have a significant role in medicine and treatment are heterocyclic compounds that have a great therapeutic role in saving humans.
The aim of this special issue is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various novel issues and developments in heterocyclic and their derivatives.
In this issue, we call on academic researchers to submit and contribute original research and reviews to try to obtain research that helps in the treatment of certain medical problems of human.
Aims and Scope:
  1. Synthesis and biological evaluation of heterocyclic compounds.
  2. Synthesis and design of active-biological fluorinated mono, bi, tri, and poly-heterocyclic compounds.
  3. Separation and isolation of natural products and study their activity.
  4. Modification of drugs to improvement their activity.
  5. Synthesis and biological applications of heterocyclic complexes.
  6. Pharmaceutical and medicinal of heterocyclic compounds.
Guidelines for Submission
Manuscripts should be formatted according to the guidelines for authors
(see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=125).

Please download the template to format your manuscript.

ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186